SECsense Logo

Mangoceuticals, Inc. 8-K Filing: Key Corporate Updates as of December 31, 2024

$MGRX
Form 8-K
Filed on: 2025-01-08
Source
Mangoceuticals, Inc. 8-K Filing: Key Corporate Updates as of December 31, 2024

Based on the provided section of the financial report, here are the key insights and information extracted:

  1. Entity Information:
  • Company Name: Mangoceuticals, Inc.
  • CIK: 0001938046
  • State: Texas (TX)
  • SEC File Number: 001-41615
  • EIN: 87-3841292
  • Address: 15110 N. Dallas Parkway, Suite 600, Dallas, TX 75248
  • Phone Number: (214) 242-9619
  1. Report Type:
  • This is an 8-K filing, which typically reports unscheduled material events or corporate changes.
  1. Date and Period:
  • Report Date: December 31, 2024
  • Period Covered: As of December 31, 2024
  1. Stock Information:
  • The company has issued Common Stock with a par value of $0.0001 per share.
  • Stock Ticker: MGRX
  • Stock Exchange: NASDAQ
  1. Financial Units:
  • The report uses USD as the primary currency unit.
  • There are references to shares as a measure of stock value.
  1. Important XML Structure:
  • The report is structured in XBRL format, which is used for financial reporting and allows for better data extraction and analysis.

Summary

Mangoceuticals, Inc. is filing an 8-K report as of December 31, 2024, detailing its corporate activities or changes. The company operates out of Texas and is publicly traded on NASDAQ under the ticker MGRX. The common stock has a nominal par value of $0.0001. The report is structured in XBRL format, indicating its compliance with SEC filing standards.